Medicare Compliance & Reimbursement - 2016 Issue 17
Physician Notes: Changes to the JW Modifier Put Money Back in the Pocket of Providers
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a CMS policy update affecting Medicare Part B drug and biological claims and notes a related documentation requirement tied to discarded amounts. It also includes a separate AMA legal update about a Tennessee Supreme Court case and its potential impact on punitive damage awards in physician-related litigation. The piece is relevant to providers, billers, and coding professionals who track Medicare payment policy and physician practice risk issues.
Why This Topic Matters
It highlights a Medicare billing change that affects how discarded drugs and biologicals are reported, along with a legal development that could influence physician liability exposure in one state.
Article Sections
-
CMS change request for the JW modifier
Overview of a CMS update affecting Medicare Part B drugs and biologicals, including the timing of the policy change and related documentation expectations.
-
In other news
A separate news item discussing an AMA-tracked Tennessee court case and its possible implications for physician litigation and awards.
What You Will Learn
- What Medicare policy area the article update addresses
- What general documentation topic is tied to the CMS change
- What broader physician legal issue is highlighted by the AMA news item
- Which audiences may need to monitor the policy and legal developments
Who Should Read This
- Physicians
- Medical coders
- Billing staff
- Practice managers
- Compliance staff
- Healthcare administrators
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com